Healthtech Startups

Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases. It uses AAV-mediated gene therapy approaches across metabolic, neurodegenerative, and other disease areas.

10 investors

Lucis provides personalized health monitoring and guidance by combining laboratory biomarker testing with educational insights and actionable recommendations. The platform helps individuals and healthcare providers identify health risks early through accredited laboratory tests across Europe, with results explained in accessible language.

10 investors

Luminai builds an AI-native operating system that unifies fragmented healthcare operational work streams to automate administrative and operational tasks across health systems. The platform addresses the rising cost of healthcare administration by automating interconnected work processes that previously required point solutions and large workforces.

10 investors

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

10 investors

Modern Animal operates a network of veterinary clinics providing primary care, urgent care, 24/7 virtual consultations, and pharmacy services for pet owners. The company serves dog and cat owners across multiple U.S. locations primarily in California, Texas, Colorado, and Arizona.

10 investors

Moons provides invisible, removable dental aligners for teeth straightening in Mexico. The company delivers personalized treatment plans with 3D smile visualization, orthodontist follow-up, and aligner sets at prices starting from 27,990 MXN.

10 investors

Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.

10 investors

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.

10 investors

Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.

10 investors

Nourish provides personalized medical nutrition therapy and patient education focused on long-term behavior change. The company delivers evidence-based nutritional care recommendations and coordinates with patients' healthcare teams to improve health outcomes.

10 investors

Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.

10 investors

OpenLoop provides telehealth platform and services that deliver virtual care to patients in their homes. The company supports healthcare clients and clinicians seeking to expand access to care delivery.

10 investors

Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.

10 investors

OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type. The device targets pediatric otitis media diagnosis to support antibiotic stewardship and reduce misdiagnosis for physicians, hospitals, and payers.

10 investors

Paloma Health offers thyroid care products including Daily Thyroid Care, an iodine-free thyroid-support multivitamin blending vitamins, minerals, and botanicals for people managing thyroid conditions such as hypothyroidism and Hashimoto's. The company sells thyroid supplements direct to consumers as part of its thyroid health offering.

10 investors

Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery. The company aims to accelerate pharmaceutical development and reduce clinical trial failure rates through human-first biological prediction models.

10 investors

ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies. The platform targets autoimmune disease, oncology, and therapeutic protein replacement applications.

10 investors

PayZen provides AI-powered, interest-free patient financing that lets patients pay medical bills over time through personalized payment plans, with pre-built EHR integrations and automated servicing for providers. It serves hospitals and health systems of all sizes, aiming to improve patient affordability while increasing provider collections.

10 investors

Pearl Health provides tools, intelligence, and support to primary care providers and healthcare organizations to deliver proactive care within value-based care models. The platform helps address healthcare system challenges by aligning clinical outcomes with financial performance for provider organizations.

10 investors

Plenna is a women's health clinic offering virtual and in-person gynecological, pregnancy, psychological, nutritional, and specialized medical services through an integrated healthcare platform.

10 investors

Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth. The company serves obstetric healthcare providers and aims to improve maternal and fetal outcomes.

10 investors

RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.

10 investors

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.

10 investors

Remedial Health provides a software platform for pharmaceutical procurement, inventory management, and financing to healthcare providers and small businesses in Africa. The platform streamlines pharmacy operations, enables real-time stock tracking, and offers flexible credit solutions.

10 investors